Determination of antimicrobial susceptibility patterns and inducible clindamycin resistance in Staphylococcus aureus

Fahriye Eksi1, Efgan Dogan Gayyurhan, Aysen Bayram

  • 1Department of Clinical Microbiology, School of Medicine, Gaziantep University, Gaziantep, Turkey. eksi@gantep.edu.tr

Abstract

Insights

This study found high rates of methicillin resistance in Staphylococcus aureus. Inducible clindamycin resistance (ICR) was present in both MRSA and MSSA strains, highlighting the need for routine ICR testing to prevent treatment failures.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Staphylococcus aureus is a significant human pathogen.
  • Antimicrobial susceptibility patterns and resistance mechanisms, such as inducible clindamycin resistance (ICR), are crucial for effective treatment.
  • High rates of methicillin resistance are a growing concern.

Purpose of the Study:

  • To determine the antimicrobial susceptibility patterns of Staphylococcus aureus isolates.
  • To investigate the prevalence of inducible clindamycin resistance (ICR) in Staphylococcus aureus.
  • To compare ICR prevalence between methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) strains.

Main Methods:

  • Analysis of 201 Staphylococcus aureus strains from clinical samples.
  • Antimicrobial susceptibility testing using the disc diffusion method.
  • Detection of inducible clindamycin resistance (ICR) via the D test in erythromycin-resistant isolates.

Main Results:

  • 50.2% of S. aureus strains were methicillin-resistant (MRSA).
  • High rates of erythromycin resistance were observed in both MRSA (53.4%) and MSSA (13.0%) strains.
  • Inducible clindamycin resistance (ICR) was detected in 6.9% of MRSA and 10.0% of MSSA isolates.

Conclusions:

  • A high prevalence of methicillin resistance was found in S. aureus.
  • No significant difference in ICR prevalence was noted between MRSA and MSSA.
  • Routine evaluation of ICR in S. aureus infections is recommended to guide therapy and prevent treatment failure.